Cargando…
Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy
BACKGROUND: Poorly differentiated midline carcinoma with a translocation between chromosomes 15 and 19, i.e. t(15;19), has been recognized as a distinct clinical entity for over a decade. This tumor affects young individuals, shows a rapidly fatal clinical course despite intensive therapy. The t(15;...
Autores principales: | Engleson, Jens, Soller, Maria, Panagopoulos, Ioannis, Dahlén, Anna, Dictor, Michael, Jerkeman, Mats |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1456975/ https://www.ncbi.nlm.nih.gov/pubmed/16542442 http://dx.doi.org/10.1186/1471-2407-6-69 |
Ejemplares similares
-
Deciphering the Role of microRNAs in BRD4-NUT Fusion Gene Induced NUT Midline Carcinoma
por: Pathak, Ekta, et al.
Publicado: (2017) -
A novel BRD4-NUT fusion in an undifferentiated sinonasal tumor highlights alternative splicing as a contributing oncogenic factor in NUT midline carcinoma
por: Stirnweiss, A, et al.
Publicado: (2015) -
Abrogation of Brd4 cellular function contributes to the oncogenic mechanisms of translocation t(15;19)-associated carcinoma
por: Wang, Ranran, et al.
Publicado: (2013) -
Genetic modifiers of the BRD4-NUT dependency of NUT midline carcinoma uncovers a synergism between BETis and CDK4/6is
por: Liao, Sida, et al.
Publicado: (2018) -
The BRD4–NUT Fusion Alone Drives Malignant Transformation of NUT Carcinoma
por: Durall, R. Taylor, et al.
Publicado: (2023)